MB
MRUS

MPM BioImpact’s Merus MRUS Stock Holding History

MPM BioImpact’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-918,310
Closed -$18.4M – 41
2022
Q3 		$18.4M Sell
918,310
-1,172
-0.1% -$28K 4.36% 9
2022
Q2 		$20.8M Hold
919,482
– – 5.78% 4
2022
Q1 		$24.3M Sell
919,482
-7,820
-0.8% -$210K 6.52% 3
2021
Q4 		$29.5M Sell
927,302
-14,646
-2% -$414K 5.38% 5
2021
Q3 		$20.7M Buy
941,948
+241,069
+34% +$5.17M 3.21% 10
2021
Q2 		$14.8M Hold
700,879
– – 2.43% 12
2021
Q1 		$14.6M Hold
700,879
– – 1.84% 11
2020
Q4 		$12.3M Hold
700,879
– – 2.16% 12
2020
Q3 		$8.41M Hold
700,879
– – 2.03% 11
2020
Q2 		$11.3M Buy
+700,879
New +$10.1M 3% 10

Other funds holding MRUS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

MPM BioImpact's MRUS Position: Q4 2022 in Review

MPM BioImpact sold out of Merus (MRUS) in Q4 2022, closing a stake of 918,310 shares — an estimated $18.4M sold.

MPM BioImpact first reported a position in MRUS in Q2 2020 and held it in 10 quarters. The position peaked at $29.5M in Q4 2021. 92 funds tracked by Wall St. Rank hold MRUS as of Q4 2022.

  • MPM BioImpact reported no remaining Merus position as of Q4 2022 after selling out during the quarter.
  • MPM BioImpact sold 918,310 Merus shares in Q4 2022, an estimated $18.4M.
  • MPM BioImpact first reported a position in Merus in Q2 2020 and held it in 10 quarters.
  • MPM BioImpact's Merus position peaked at $29.5M in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Merus as of Q4 2022.

Based on MPM BioImpact's 13F filing for Q4 2022, filed 14 Feb 2023.